STAT+: Eye docs urge Medicare to lower insurance hurdles amid shortage of repackaged Avastin
Due to a shortage of a widely used compounded medicine for serious eye diseases, two…
Category: Medicare
STAT+: UnitedHealth’s profit jumps as medical costs come in lower than expected
UnitedHealth Group has made it clear that more people, especially older adults, are seeing their…
STAT+: Medicare to cover more brain scans related to Alzheimer’s drugs
Medicare has officially expanded its coverage policy for brain scans that detect a brain plaque…
STAT+: Humana CEO Bruce Broussard to step down next year
Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading…
STAT+: Medicare may plan to negotiate drug prices, but some states are taking their own steps to lower costs
Anticipation may be high that Medicare can wring lower prices out of drugmakers, but a…
STAT+: Bernie Sanders bashes nonprofit hospitals over their tax breaks
WASHINGTON — Hospitals get tax breaks that are worth far more than the value of…
.jpg)
Robert F. Kennedy is pitching centrism on health care, even on abortion
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…
What’s next in the Kaiser Permanente strike
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
.jpg)
Medicare’s proposal on nursing home staff is ‘insanity,’ key expert says
Some of the country’s top Medicare experts aren’t sold on a new Biden administration plan…
The future of health care in the House
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…
The stability of $0 premiums in Medicare Advantage
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Obama-era Medicare innovation initiative doesn’t save money after all
WASHINGTON — A key Obama-era initiative was supposed to save Medicare money by testing new…
STAT+: Cigna to pay $172 million in Medicare Advantage fraud settlement
Health insurer Cigna is paying more than $172 million to settle allegations that it committed…
STAT+: Court allows Medicare drug price negotiation to proceed
WASHINGTON — A federal court judge allowed a new Medicare drug price negotiation program to…
STAT+: GOP senator probes drug discount programs at Cleveland Clinic, Bon Secours
WASHINGTON — The top ranking Republican on the Senate health committee is launching an investigation…
STAT+: Drug industry payments to eye docs boosted Medicare spending on pricier treatments
Ophthalmologists who accepted payments from drug companies were less likely to prescribe a cheaper medicine…
Did you have Obamacare on your GOP debate bingo card?
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…
STAT+: 6 ways the government could help address drug shortages, including in cancer
WASHINGTON — Republicans and Democrats alike want to stop drug shortages from happening. The vexing…
STAT+: Senate committee chair tries to spark negotiations to keep Medicare solvent
WASHINGTON — The Senate Budget Committee started what could become a bipartisan effort to extend…
STAT+: With Menendez indictment, pharmaceutical industry could lose a key ally
WASHINGTON — With mounting calls for embattled Sen. Bob Menendez to resign, the pharmaceutical industry…
Will a government shutdown stall Medicare drug price negotiations?
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…
STAT+: Medicare Advantage plans for dual-eligible enrollees set to get Senate scrutiny
The Senate has set its eyes on regulating insurance plans for some of the most…
Kaiser Permanente workers announce an official strike date
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Hearing on Medicare drug price negotiation gets unusually heated
WASHINGTON — Republicans and Democrats fought it out over Medicare drug price negotiation Wednesday at…
STAT+: PBMs were the target of House hearing, but pharma wasn’t spared criticism
WASHINGTON — Congress wants to reform PBM business practices to help lower the cost of…
STAT+: What happened to the House vote on health care price transparency?
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…
STAT+: Medicare wants to increase payments for heart rehab. Hospitals see an opening to get more
Medicare plans to pay more for a type of cardiac rehabilitation that takes place in…
STAT+: Chamber of Commerce, government clash at first court hearing on Medicare drug prices
WASHINGTON — Attorneys for the U.S. Chamber of Commerce and the federal government sparred Friday…
STAT+: Medicare is urged to monitor how rebates affect Part D drug spending, but agency demurs
The U.S. government should monitor the effect that rebates have on Medicare Part D plans…
STAT+: What to make of Biden’s latest cancer moonshot efforts
WASHINGTON — The next chapter of President Biden’s moonshot to end cancer has landed. While…
STAT+: Walmart may buy concierge Medicare Advantage provider ChenMed. But will it scale?
Walmart seems poised to increase its health care footprint by buying value-based senior care company…
Is there a path forward for PEPFAR?
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…
STAT+: House transparency, PBM reform bill gains bipartisan support
WASHINGTON — A Democrat has signed on to a legislative package that would require health…
Opinion: How the drug price negotiation program could affect Medicare Part D beneficiaries
After the recent announcement of the first 10 drugs selected for Medicare price negotiation, much…
A new House health package & hospitals’ new site-neutral talking points
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…
STAT+: Why the drug industry’s opaque warnings on price negotiations fall short
Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry…
Opinion: What does ‘bona fide competition’ actually mean in the biologics market?
On Aug. 29, Medicare released its highly anticipated list of 10 therapies for which it…
STAT+: House committees strike deal on health transparency, PBM reform package
WASHINGTON — Republicans on three key House committees have reconciled their differing legislative packages to…
STAT+: Astellas withdraws lawsuit after evading Medicare drug price negotiations
WASHINGTON — Astellas was so sure that one of its drugs was going to be…
STAT+: Humana sues Biden administration over Medicare Advantage audit rule
Humana sued the federal government Friday, arguing that this year’s new rule to claw back…
STAT+: The curious case of J&J’s Stelara, the unluckiest drug on Medicare’s list
WASHINGTON — Ninety-eight days may end up costing Johnson & Johnson. When Medicare this week…
STAT+: A new paper suggests a simple fix to the primary care physician shortage
The U.S. is running low on primary care physicians, with an estimated shortage of between…
STAT+: Winners and losers from Medicare’s list of drugs subject to price negotiation
On Tuesday morning, the U.S. Department of Health and Human Services unveiled its long-awaited list…
Here are the 10 drugs that will be up first for Medicare price negotiation
WASHINGTON — Medicare on Tuesday announced the first 10 drugs selected for a new drug…
STAT+: Feds fine Medicare Advantage plans for overcharging their members
The federal government has started penalizing Medicare Advantage insurers that have one common, glaring problem:…
Mid-year drug price hikes are back despite Inflation Reduction Act
It’s almost a tradition. At the start and halfway points of each year, many pharmaceutical…
Opinion: Medicare beneficiaries deserve access to genetic counselors
Precision medicine driven by genetic health care is knocking on the door. It offers hope…
STAT+: Genentech weighs slow-walking ovarian cancer therapy to make more money under drug pricing reform
WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental…
STAT+: Medicare slashes safety net hospital payments on estimate that more people have insurance
The federal government will pay hospitals that treat poor and uninsured patients almost $1 billion…
STAT+: Medicare wants to improve Alzheimer’s care, but sidesteps drug prices
WASHINGTON — Medicare announced today a pilot program aimed at improving dementia care and reducing…